The formation and plasticity of synaptic connections rely on regulatory interactions between pre-and postsynaptic cells. We show that the Drosophila heparan sulfate proteoglycans (HSPGs) Syndecan (Sdc) and Dallylike (Dlp) are synaptic proteins necessary to control distinct aspects of synaptic biology. Sdc promotes the growth of presynaptic terminals, whereas Dlp regulates active zone form and function. Both Sdc and Dlp bind at high affinity to the protein tyrosine phosphatase LAR, a conserved receptor that controls both NMJ growth and active zone morphogenesis. These data and double mutant assays showing a requirement of LAR for actions of both HSPGs lead to a model in which presynaptic LAR is under complex control, with Sdc promoting and Dlp inhibiting LAR in order to control synapse morphogenesis and function.
Introduction
The neuronal synapse is a specialized intercellular junction, the morphogenesis of which is vital for the function and plasticity of neural circuits. At the cell surface, multiple cell and substrate adhesion molecules work with each other and with extracellular matrix (ECM) proteins to maintain the physical bond between neuron and target and to regulate synapse form and function (reviewed by Yamagata et al. [2003] ).
One class of ECM molecule particularly important for neuronal connectivity development is the heparan sulfate proteoglycans (HSPGs) (reviewed by Van Vactor et al. [2006] and Yamaguchi [2001] ). Heparan sulfate (HS) is composed of a repeating dissaccaride unit (glucuronic acid and N-acetyl-glucosamine), which is then modified by deacetylation, epimerization, and sulfation to provide anionic binding sites for a number of extracellular partners (reviewed by Bernfield et al. [1999] ).
Although the secreted HSPGs Agrin and Perlecan are well known as regulators of synapse assembly at the vertebrate neuromuscular junction, recent data suggest that cell surface HSPGs may also be important for synaptic development. Syndecan-2 localizes to multiple classes of synapses in the mammalian hippocampus (Hsueh and Sheng, 1999; Hsueh et al., 1998) . Consistent with the synaptic accumulation of Syndecan-2, treatment of hippocampal tissue with heparinase to remove HS prevents efficient long-term potentiation (LTP) in CA1 pyramidal neurons, thus implicating HSPGs in synaptic plasticity (Lauri et al., 1999) . Because LTP has been linked to morphological dynamics and maturation of the dendritic spines that process hippocampal inputs, it is particularly intriguing that misexpression of Syndecan-2 can induce accelerated morphological maturation of rat hippocampal dendritic spines in cell culture (Ethell and Yamaguchi, 1999) . This suggests that Syndecan may play an important role in synaptic development and/or plasticity. However, in vivo elimination of Syndecan (or Syndecans) is needed to show the requirement of this HSPG family at the synapse.
Although the genetic analysis of Syndecan function in the mammalian central nervous system (CNS) is complicated by the existence of several family members, a single Syndecan gene (Sdc) is present in Drosophila (Spring et al., 1994) . Analysis of Sdc function in Drosophila has highlighted roles in axonal pathfinding (Johnson et al., 2004; Rawson et al., 2005; Steigemann et al., 2004; Fox and Zinn, 2005) ; however, the function of Sdc at the synapse is unknown. By far the best-characterized Drosophila synapse is the larval NMJ. Unlike vertebrate and C. elegans NMJs, the Drosophila counterpart is glutamatergic, analogous to the majority of mammalian CNS excitatory synapses (Gramates and Budnik, 1999) . By larval hatching, nascent NMJs have formed in the periphery that will grow extensively throughout larval life (see Figure 1A for a schematic of ventral muscles and motor nerves). At the latest stage of larval development (third instar), presynaptic arbors fan out extending multiple branches decorated with many round synaptic varicosities (''boutons'') that contain the active zones that organize glutamate release ( Figure 1B) .
Another class of cell surface molecules involved in synapse development is the receptor protein tyrosine phosphatases (RPTPs) (reviewed by Johnson and Van Vactor [2003] ). LAR family RPTPs have been identified with roles in synapse formation in Drosophila (Kaufmann et al., 2002) , C. elegans (Ackley et al., 2005) , and vertebrates (Dunah et al., 2005) . Although relatively few RPTP-ligand interactions have been tested for function in vivo, several molecules have been identified that bind to LAR-family receptors, including LamininNidogen complexes and HSPGs. Although genetic data implicate Nidogen in the synaptic LAR pathway of C. elegans (Ackley et al., 2005) , synaptic HSPG-LAR interactions have not been tested in any organism.
In this study, we examine the synaptic functions of two HSPGs in Drosophila: Syndecan (Sdc) and the glycosylphosphatidyl-inositol (GPI) anchored glypican Dallylike (Dlp). We find that Sdc is required for normal levels of morphological growth at the larval NMJ without obvious effects on the electrophysiology of the synapse. In contrast, Dlp is necessary to regulate the form and physiological function of active zones but plays no apparent role in regulation of bouton addition. Becuase LAR-family receptor protein tyrosine phosphatases have been shown to bind HSPGs in different contexts (Aricescu et al., 2002; Fox and Zinn, 2005) , and because LAR regulates both NMJ growth and active zone structure in Drosophila (Kaufmann et al., 2002) , we asked if Sdc and Dlp might function through interactions with LAR. We find that both Sdc and Dlp bind to Drosophila LAR (A and B) Diagrams of the ventral body-wall muscles (numbered) and motor nerves from the dorsal aspect of the Drosophila larva (A) and the 6/7 neuromuscular junction (B). The intersegmantal nerve b (red) projects to the ventral longitudinal muscle group (gray); muscles 6 and 7 (dark gray) are part of this group and are dually innervated by the most proximal branch (b). An individual synaptic bouton showing the location of the subsynaptic reticulum (SSR) and a representation of the active zone are shown at right. (C) Immunostaining with anti-HRP and antiSdc antibodies at the 6/7 NMJ. Sdc is highly concentrated at synaptic boutons (asterisks in merge).
(D) Higher magnification shows that the majority of Sdc appears to exist in a halo surrounding FasII. (E) Sdc mutant larvae (Sdc P /Df48,ubi-sara) lack all detectable Sdc staining at the 6/7 NMJ. (F) Dlp and Sdc immunoreactivity show high degrees of overlap within NMJs at the muscle 6/7 cleft. (G) Higher magnification images of terminal boutons show that Dlp localizes to punctate structures that are contained within the broader Sdc distribution (arrowheads). (H) Drosophila LAR (Dlar) localizes preferentially to terminal boutons (D) and shows a high degree of overlap with Sdc at the 6/7 NMJ. (I and J) A single plane of optical section from the confocal microscope allowed a linescan (white line) of relative fluorescence intensity to compare the Sdc and HRP epitopes. A plot of the intensity data as a function of position is shown in (J). (K) Immunostaining with anti-Sdc and antiFasII antibodies to the NMJ on muscles 12 and 13 shows that Sdc localizes preferentially to type Is and Ib boutons (arrowhead) but is absent from type II boutons (asterisks). Scale bar in (E) represents 50 mm for (C), 5 mm for (D) and (E), and 3 mm for (F).
at high affinity. Moreover, multiple double mutant experiments indicate that both Sdc and Dlp act upstream of LAR. Our results reveal a complex regulatory relationship between LAR and two HSPGs that control distinct aspects of synapse biology, with Sdc acting to promote LAR function and NMJ growth, and Dlp acting to antagonize LAR function and influence active zone structure and physiology.
Results
Drosophila HSPGs Localize to the Neuromuscular Junction Syndecan-family HSPGs have been localized to vertebrate glutamatergic synapses (Hsueh and Sheng, 1999; Hsueh et al., 1998) ; however, Sdc distribution at analogous synapses in Drosophila was unknown. Using confocal microscopy, we examined wild-type third instar larval fillets and compared the staining patterns of antibodies against Drosophila Sdc, the presynaptic membrane marker horseradish peroxidase (aHRP), and the cell adhesion molecule Fasciclin II (aFasII). The localization of Sdc is quite specific to the synapse, with little or no protein detected along motor axons or branches that are free of boutons ( Figures 1C and 1D) , despite abundant accumulation along motor axons at early stages of development (Johnson et al., 2004) . To confirm the specificity of the Sdc staining at the NMJ, we examined Sdc mutant larvae (Sdc l(2)10608 /Df[2R]48, ubi-sara; see Experimental Procedures) and no Sdc signal was detected ( Figure 1E ).
Inspection of wild-type NMJs revealed that Sdc staining extends in a halo-like distribution around type Ib and Is boutons ( Figures 1D and 1I ). This pattern indicates that the majority of synaptic Sdc is found either on the muscle surface or in the space between the presynaptic membrane and the subsynaptic reticulum (SSR) (see Figure 1B ). To examine Sdc distribution more thoroughly, we performed line scans of fluorescence intensity comparing the Sdc signal to that of the HRP epitope ( Figure 1J ). Although Sdc and HRP show some overlap, most of the Sdc surrounds the bouton. Sdc is absent from type II boutons that lack SSR structures (e.g., on muscles 12 and 13; Figure 1H ).
Although anti-Dlp antibodies have been used to characterize Dlp localization during epitheilial patterning and axon guidance (Johnson et al., 2004; Kirkpatrick et al., 2004; Rawson et al., 2005) , the synaptic localization of glypicans have not been described in any organism. The localization of Dlp and Sdc overlapped at the NMJ ( Figure 1F ). Like Sdc, very little Dlp was found along motor axons or bouton-free regions of the presynaptic arbor. Careful examination revealed that Dlp accumulates in punctate structures that are contained within a broader distribution of Sdc ( Figure 1G , arrowheads), suggesting that Dlp is restricted to a subset of synaptic space.
Syndecan Is Required to Promote Normal Synapse Growth
Given the synaptic localization of Sdc and Dlp, we wondered if they might be required for some aspect of synaptogenesis. After first ruling out defects in embryonic motor axon guidance in both Sdc and Dlp zygotic loss-of-function (LOF) mutants (see Supplemental Data), we examined larval NMJs with several anatomical markers. Using the presynaptic markers HRP and MAP1b/Futsch, we compared several wild-type strains with mutants lacking Sdc or Dlp. No gross defects in the branched structure of presynaptic terminals were observed (Figures 2A-2C ). For a more detailed view of synapse structure, we examined a series of additional markers, including the presynaptic active zone antigen NC82, the SSR marker Dlg, and glutamate receptors (GluRIII) that cluster on the postsynaptic membrane. No obvious defects in the levels or distribution of these markers were observed in Sdc mutants ( Figures 2D-2G ). We also found no defects in levels or localization of the synaptic vesicle markers Synaptotagmin (Syt) and Cysteine-string protein (CSP), or the endocytic marker Endophillin (not shown). Similar results were obtained for Dlp mutants with HRP, Futsch, FasII, NC82, GluRIII, Sdc, and LAR as markers (not shown).
Although we found no alteration in the distributions of synaptic marker proteins in Sdc mutants, we did discover a defect in synaptic growth. At the crawling third instar stage, wild-type NMJs contain a stereotyped, segment-specific number of boutons reflecting the steady growth of the synapse over larval life. When we quantified bouton number at NMJs formed on muscles 7 and 6 in a wild-type strain (Canton S) and in different Sdc alleles, we found a highly significant reduction in bouton number (over 35% in Sdc l(2)10608 /Df48,ubi-Sara, p < 10 28 ) ( Figure 2H , triple asterisk); comparable phenotypes were observed at abdominal segments A2 and A3 (not shown). When wild-type was compared to a control genotype with normal levels of Sdc and a genetic background identical to the Sdc mutant strain, no significant difference was found (P12357/P12345) ( Figure 2H ). We used mitotic recombination as an additional control for genetic background effects to remove flanking polymorphisms from the Sdc chromosome, and the NMJ phenotype of the recombinant was not significantly less severe than the original Sdc mutant (p = 0.2) ( Figure 2H ). To be certain that this Sdc phenotype did not reflect reduction in the overall growth of Sdc mutant tissues, we compared the size of muscles 6 and 7 in mutants and controls but found no significant difference (mean muscle areas were 79698 mm 2 in wild-type compared to 78702 mm 2 in Sdc mutants; p = 0.8). Thus, we concluded that Sdc is required for the normal addition of boutons throughout NMJ growth.
We next asked if we could rescue the Sdc NMJ phenotype with a cDNA transgene under the control of a tissue-specific GAL4 driver. We found that expression of an Sdc construct under control of a presynaptic driver (elav-GAL4) provided nearly complete rescue of the NMJ growth defect (p < 10 24 ) ( Figure 2H , double asterisk). The localization of the UAS-Sdc transgenic protein (driven by elav-GAL4 in an Sdc LOF background) was indistinguishable from the pattern of endogenous Sdc in wild-type ( Figure 2J ). When we used a postsynaptic driver (24B-GAL4) to express the same UAS-Sdc transgene, we found only a very weak rescue activity (15.5% recovery) ( Figure 2H , single asterisk), suggesting that Sdc acts primarily on the presynaptic membrane.
As a test of Sdc specificity at the NMJ, we examined synapses lacking Dlp. Interestingly, the number of boutons in the dlp mutant were within normal range ( Figure 2H ). In the embryonic CNS, we previously found that elevation of Dlp expression can rescue some of the midline axon guidance defects seen in Sdc mutants (Johnson et al., 2004) , suggesting functional redundancy between the two HSPGs. As a further test of specificity at the synapse, we expressed wild-type Dlp in the Sdc mutant but found no rescue of the growth defect /Df48,ubi-sara mutants (p = 9.5 3 10 29 ; triple asterisk) or a recombinant Sdc chromosome (Sdc P recomb/Df48,ubi-sara mutants) have significantly fewer boutons compared to Canton S or a genetically matched wild-type control (P12357/P12345). Presynaptic expression of UAS-Sdc rescues the bouton reduction phenotype (p = 2.3 3 10
25
; double asterisk), whereas postsynaptic expression provides only limited rescue (single asterisk). UAS-Dlp is unable to rescue the Sdc phenotype, and mutations in dallylike (dlp 1 /dlp 2 ) do not cause a significant reduction in bouton number. Blue bar represents SEM of Canton S, and pink bar represents SEM of Sdc P /Df48,ubisara. (I and J) Sdc distribution in an Sdc mutant expressing UAS-Sdc under a neuron-specific elav-GAL4 source ([K] , also used for rescue in [H] ) is equivalent to wild-type (J). (K and L) Elevated expression of UAS-Sdc (GOF) in wild-type larvae under either presynaptic elav-GAL4 (L) or postsynaptic 24B-GAL4 both induce a significant percentage increase in bouton number compared to GAL4 alone (blue bars represent SEMs of GAL4 alone control values). Scale bar represents approximately 50 mm in (A)-(C), 4 mm in (D)-(G), and 2 mm in (J) and (K).
( Figure 2H ). Interestingly, elevation of Dlp enhanced the Sdc phenotype, suggesting that there might be an antagonistic relationship between the two HSPGs. Thus, in the context of synapse growth, Sdc function appears to be highly specific compared to Dlp.
In cell culture, elevated expression of vertebrate Syndecan-2 can accelerate the maturation of glutamatergic synapses (Ethell and Yamaguchi, 1999) , suggesting that HSPG levels may be instructive for synapse growth. To ask if Sdc can achieve this effect in vivo, we tested whether Sdc is limiting for NMJ growth in Drosophila. Using GAL4 drivers specific to neurons or muscle cells, we misexpressed Sdc in a wild-type background. Presynaptic elevation of Sdc increased bouton number compared to GAL4 alone (p < 0.001) ( Figure 2K ). Interestingly, despite the poor rescue activity of postsynaptic Sdc, muscle expression of Sdc in a wild-type background gave a similar increase in synapse size (p < 0.001) ( Figure 2K ). This gain-of-function (GOF) phenotype was the opposite of that observed in the Sdc LOF, demonstrating that Sdc is limiting for synapse growth.
Dallylike Regulates Synaptic Transmission and Active Zone Morphology
Cell surface HSPGs have been implicated as regulators of synaptic function by gross enzymatic depletion of HS (e.g., Lauri et al. [1999] ). To test if specific HSPGs are indeed required for normal synapse physiology, we measured the excitatory junctional potential (EJP) elicited by stimulation of the intersegmental motor nerve trunk in crawling third instar larvae at 1.0 mM extracellular Ca 2+ , comparing a wild-type strain (Oregon R, OR) to a strong Sdc LOF genotype (Sdc Figures 3A and 3B ). Compared to controls, Sdc mutant EJPs were not significantly reduced (p = 0.9) (Figures 3A, 3B, and 3D). We also measured the amplitude and frequency of spontaneous release events (miniature events; mEJPs); although there seemed to be a slight decrease relative to OR, it was not statistically significant (p = 0.8 and 0.6, respectively) ( Figures 3E and 3F ). This suggests that Sdc mutant NMJs accomplish some type of functional compensation for their decreased overall size.
We next examined the physiology of dlp mutants. Here, we found a significant increase in EJP amplitude (45% higher than OR in dlp 1 /dlp 2 , p = 0.0001) ( Figures  3C and 3D ), without a significant change in muscle input resistance. Comparable EJP amplitudes were seen when the dlp 1 allele was examined over a deletion at the locus (not shown). To confirm that loss of Dlp alone induced the change in EJP amplitude, we also performed a rescue experiment with a full-length wildtype UAS-Dlp transgene; the wild-type Dlp transgene restored EJP values to normal levels (UAS-Dlp[+];dlp 1 / dlp 2 EJPs were 32.4 mV [n = 9] compared to 32.5 mV observed in OR [n = 8]; p = 0.98). Similar to Dlp function during axon guidance (Rawson et al., 2005) , GAL4 activity was not required to achieve full rescue of the dlp synapse phenotype, suggesting that very small quantities of Dlp are sufficient to restore synaptic function.
The dlp neurotransmission phenotype could reflect increased glutamate release or elevated postsynaptic sensitivity. To distinguish between these possibilities, we analyzed mEJPs. The mean amplitude of dlp mutant mEJPs was not significantly different from wild-type (p = 0.2) ( Figure 3E ). The frequency of mEJPs was also normal in dlp mutants (p = 0.5) ( Figure 3F ), suggesting that the defect was specific to the evoked release mechanism. To compare the number of glutamate quanta released with each presynaptic stimulus, we calculated quantal content values with mEJP amplitude to determine quantal size correcting for nonlinear summation and found a significant increase in dlp mutants relative to wild-type (64%, p = 0.0002) ( Figure 3G ). Thus, in contrast to Sdc, Dlp is required for normal synapse physiology, acting to restrict the number of quanta released per stimulus.
Neurotransmitter release is orchestrated at special sites on the presynaptic membrane called active zones (AZs) that can be visualized at an ultrastructural level. We asked if there might be a morphological correlate to the functional defects observed in dlp mutants. Serial section transmission electron microscopy (EM) was performed for dlp, Sdc, and a wild-type strain; multiple type Ib boutons from several animals were examined for each genotype. We found no gross alteration in overall NMJ structure. Key structures such as the subsynaptic reticulum (SSR), synaptic vesicles, AZs, and t bars were present in both HSPG mutants ( Figures 3H-3P) .
To obtain a quantitative metric of AZ structure, we measured the dimensions of AZs in the HSPG mutants. In Sdc mutants, there was no significant change in AZ area relative to controls (p = 0.7) ( Figure 3Q ), consistent with the absence of a physiological phenotype. However, dlp mutant AZs were significantly smaller than wild-type or Sdc (p = 0.02) ( Figure 3Q ). A decrease in AZ area alone could not explain the increased quantal context in dlp mutants, so we counted the number of AZs per bouton and found that although Sdc mutants are not significantly different from control, dlp mutants show a roughly 2-fold increase in AZ density ( Figure 3R ). Finally, we asked if Dlp is limiting for AZ morphogenesis. EM reconstruction after postsynaptic elevation of UASDlp revealed a nearly 2-fold increase in AZ area, precisely the opposite of dlp loss of function ( Figure 3S ). Together with our analysis of NMJ growth, the physiological and ultrastructural data reveal striking specificity in HSPG action at the synapse, with Sdc controlling NMJ growth and Dlp controlling AZ morphogenesis.
Sdc and Dlp Bind to LAR
Among candidate receptors that might mediate the synaptic effects of HSPGs, the LAR family of receptor protein tyrosine phosphatases (RPTPs) was particularly attractive because the LAR ortholog PTP-s binds to two vertebrate proteoglycans, Agrin and Collagen XVIII (Aricescu et al., 2002) , and LAR is required for synapse growth as well active zone form and function in Drosophila (Kaufmann et al., 2002) . Moreover, while this manuscript was in review, binding between LAR and Sdc was described in the Drosophila embryo (K. Zinn, personal communication; Fox and Zinn, 2005) .
To test for a cell-surface interaction between LAR and Sdc, we constructed a fusion protein with the Drosophila Sdc extracellular (EC) domain linked to an alkaline phosphatase (AP) tag and used it to probe Drosophila S2 cells expressing a cDNA encoding an epitope-tagged /Df(2R)48,ubi-sara (n = 6), and dlp 1 /dlp 2 (n = 11).
LAR receptor ( Figure 4C ). Sdc-AP showed little binding to untransfected S2 cells but bound strongly to cells transfected with a LAR construct (p < 0.0001) (Figures 4A and 4B) . In view of this interaction between Sdc and LAR, we wondered if LAR might also associate with Dlp. Like Sdc-AP, Dlp-AP bound effectively to S2 cells in a LAR dependent fashion. In fact, in both quantitative assays ( Figure 4A ) and cell culture binding assays ( Figure 4B ), Dlp-AP consistently bound to LAR-transfected cells to a greater extent than did Sdc-AP (p < 0.001) ( Figure 4A ), suggesting that LAR might have a greater affinity for Dlp than for Sdc.
To confirm the binding of LAR with Sdc and Dlp in a cell-free system and to characterize the interaction in more detail, we used a quantitative in vitro protein binding assay in which Dlp-AP or Sdc-AP fusion proteins were tested for binding to a LAR-Fc fusion protein. Sdc-AP displayed saturable binding to LAR-Fc (Figure 5A ). Scatchard analysis of the binding data revealed a dissociation constant (K D ) of approximately 13 nM for Sdc-LAR binding ( Figure 5B ).
To localize the binding region within LAR and within Sdc, we analyzed mutant proteins. Deletion mutants of LAR showed that Sdc associated specifically with the Ig but not the FN domains of the LAR extracellular domain ( Figure 5E ). A mutant Sdc-AP, in which all GAG attachment serine residues have been changed to threonines (ST3-AP), did not bind to LAR ( Figure 5E ). Moreover, heparitinase treatment of Sdc-AP to remove HS chains also abrogated LAR binding ( Figure 5F ). In contrast to vertebrate PTP-d (Wang and Bixby, 1999) , we were unable to detect homotypic binding of the Drosophila LAR ectodomain to itself in this assay (not shown).
Like Sdc, Dlp-AP showed high-affinity, saturable binding to recombinant LAR-Fc protein ( Figure 5C ) with a K D of approximately 8 nM ( Figure 5D ). Interestingly, the affinity of Dlp for LAR was about twice as strong as that of Sdc in repeated experiments ( Figure 5D and data not shown). Thus, the difference between Sdc and Dlp in the efficiency of their binding to the surface of LAR-transfected cells (Figure 4 ) might be explained solely by the difference between their K D values (Figure 5) . Like Sdc, Dlp-AP binding to LAR-Fc was specific to the Ig domains and was highly sensitive to heparinase ( Figures 5E and 5F ).
Syndecan and LAR Act in a Common Genetic Pathway
The synapse growth phenotype that we discovered in Sdc mutants (Figure 2) is essentially identical to that observed in LAR mutants (Kaufmann et al., 2002) . In addition, we find overlap between Sdc and LAR surrounding the presynaptic membrane ( Figure 1H ). These features, together with the biochemical association of Sdc and LAR (Figures 4 and 5) , suggest that Sdc acts in the LAR pathway. If Sdc function relies upon LAR activity, we would predict that a reduction in LAR should enhance a weak Sdc phenotype. We introduced one null allele of LAR (LAR 5.5 /+) into an Sdc hypomorphic background (Sdc PKG /Df48,ubi-sara) and found that LAR/+ enhanced the NMJ growth defect of Sdc to a level approaching that of the LAR homozygote ( Figure 6A) .
A more stringent way to test if two genes act in the same pathway is to compare their single and double homozygous phenotypes. If Sdc and LAR act in independent parallel pathways, the two phenotypes should be additive. However, if they act in the same pathway, the double null should display the same phenotype as the single null. We used genetic recombination to combine null alleles of Sdc and LAR and found that the double mutant is indistinguishable from the LAR null alone ( Figure 6B ). Because Sdc is limiting for synapse growth in Drosophila (Figures 2K and 2L ), we could demonstrate this in a complementary way by asking if LAR is absolutely required for Sdc to promote the addition of new boutons. We compared presynaptic elevation of Sdc in a wild-type background to the same expression in a LAR null background. Sdc gain of function in a LAR mutant background was identical to LAR alone ( Figure 6B) , showing that all of the Sdc growth-promoting activity is dependent on LAR.
Dallylike Opposes LAR Function
Although the synaptic localization and high affinity binding of Dlp and LAR suggested that Dlp might act in the LAR pathway, the active zone morphology and electrophysiology phenotypes of dlp and LAR mutants are opposite (Figure 3) (Kaufmann et al., 2002) . This suggested that Dlp might act to antagonize synaptic LAR. If this were true, we reasoned that overexpression of Dlp might inhibit LAR function and thus phenocopy a LAR mutant. Using UAS-Dlp, we found significant decreases in bouton numbers with either presynaptic or postsynaptic GAL4 drivers, although a much stronger effect was seen from muscle expression (14% decrease with elav-GAL4 compared to 30% decrease with 24B-GAL4) ( Figure 6D ). Although this gain-of-function phenotype was similar to LAR LOF, satisfying our prediction, we further reasoned that an instructive upstream antagonist should be able to block the effect of LAR overexpression. Indeed, although overexpression of LAR alone increased bouton number, simultaneous elevation of Dlp and LAR gave a phenotype the same as Dlp alone ( Figure 6E) .
If LAR and Dlp were to act in separate parallel pathways, we would predict that Dlp overexpression combined with a LAR null would have additive effects in Neuronreducing NMJ size; however, if both genes function in the same pathway, the combined phenotype should be no stronger than the LAR null alone. We found the latter to be true, with no significant difference between LAR ;24B-GAL4/UAS-Dlp ( Figure 6F ). Together, these gain-of-function assays support the hypothesis that Dlp antagonizes LAR in vivo.
Dallylike Acts Uptream of LAR to Regulate Tyrosine Phosphorylation
A direct way to show that Dlp regulates LAR receptor signaling activity is to assay the activation state of downstream effector proteins. In our previous analysis of LAR signaling, we discovered that the phosphoprotein Enabled (Ena): (1) displays a LAR-like axon phenotype, (2) binds directly to the LAR cytoplasmic domain, and (3) can be dephosphorylated by LAR (Wills et al., 1999) . Our previous assays for LAR catalysis were performed in vitro, and so we wanted additional confirmation that Ena interacts with the LAR catalytic active site in an intact cell. For this purpose, we constructed active site point mutations that allow PTPs to bind phosphorylated substrates and initiate the first step of catalysis but then fail to release the bound substrate (''substrate trap'') (Garton et al., 1996) . Using wild-type and substrate trapping mutations (D-A in D1 and D2 PTP domains) in epitope-tagged LAR catalytic domains, we asked if endogenous Ena in Drosophila S2 or KC167 cells binds preferentially to either construct. As assayed by affinity purification and Western blot, Ena bound to the wild-type LAR PTP domains, with no binding to the tag alone ( Figure 7A ). However, the LAR substrate trap bound far more effectively to Ena under identical conditions ( Figure 7A ), supporting our previous genetic hypothesis that Ena is a physiological LAR substrate.
To provide a functional assay for LAR activity, we then used RNA interference (RNAi) in Drosophila KC167 cells followed by immunoprecipitation of endogenous Ena ( Figure 7B ). When we knocked down endogenous LAR and then assayed Ena by anti-phospho-tyrosine (pTyr) Western blot, we found a reproducible increase in Ena phosphorylation (p = 0.016) ( Figures 7B and 7C) , as predicted from our substrate-trapping data. When we used RNAi to reduce endogenous Dlp expression, we found the opposite effect on Ena phosphorylation (p = 0.002) ( Figures 7B and 7C) , consistent with a model in which Dlp acts to inhibit LAR activity. To test if Dlp acts upstream in a LAR-dependent fashion, we performed a double-RNAi of both proteins. Here, we found that the LAR phenotype was epistatic to Dlp ( Figures 7B  and 7C ). This last experiment demonstrates that Dlp 
Ig Domains and Catalytic Activity Are Essential for Synaptic LAR
A model in which Sdc and Dlp regulate LAR activity through direct binding would predict that the Ig domains and catalytic activity of the receptor be necessary for NMJ development. However, in a recent analysis of LAR domains required for rescue of lethality, we found that neither of these conserved features were absolutely required (Krueger et al., 2003) . Thus, we wanted to reexamine this question in the context of the NMJ. Before testing different LAR mutant trangenes, we asked where full-length, wild-type LAR must be expressed to rescue ) to a wild-type control (Canton S) and to lines expressing GAL4 in this background. Although neither GAL4 alone nor postsynaptic expression of a full-length, wild-type LAR (Dlar [+] ) rescued the A2 6/7 NMJ phenotype, presynaptic LAR expression restored the mutant NMJ (asterisk). When transgenes lacking either the FN domains 2-9 (DFN), Ig domain 1-3 (DIg), or the two catalytic cysteine residues in PTP domains D1 and D2 (2xC-S) were assayed with elav-GAL4, only UAS-DlarDFN provided significant rescue activity (p = 0.017; double asterisk).
a LAR null NMJ phenotype (see Experimental Procedures). Although muscle expression of UAS-LAR(+) with the GAL4 driver 24B did not rescue the LAR mutant phenotype, neuron-specific expression with elav-GAL4 restored LAR NMJs to normal size ( Figure 7D , double asterisk). We then expressed three mutant transgenes of LAR under the same elav-GAL4 driver in the null background: DIg (removing all three Ig domains), DFN (removing FN repeats 2-9), and 23C-S (eliminating catalytic activity in both PTP domains). However, at the NMJ only DFN provided any significant rescue activity compared to the LAR null alone (p = 0.017) ( Figure 7D , single asterisk), demonstrating that LAR Ig domains and PTP catalysis are essential for synapse growth, as predicted by the biochemical and genetic data linking Sdc and Dlp to LAR function.
HSPG Competition for LAR Binding and Synapse Growth
Multiple experiments suggest that Sdc and Dlp exert opposing effects on LAR during synapse development. Because Sdc and Dlp are both present at the NMJ, this raised questions of whether the two HSPGs compete for access to LAR and which HSPG is dominant for binding and biological activity.
We first asked if the HSPGs can effectively compete with each other for binding to the LAR receptor. To produce a generally applicable vector for use in competition binding experiments with AP-tagged proteins, we constructed a version of the AP tag lacking catalytic activity. This construct was produced from the APtag-5 vector (Flanagan et al., 2000) by mutating Ser109 at the enzyme active site to Alanine, producing vector APtag-5 SA . Competition binding experiments were then performed by quantifying the bound AP activity after treating immobilized Fc-tagged LAR with AP-tagged HSPG, in the presence or absence of competing AP SA -tagged proteins. The results show that Sdc and Dlp fusion proteins can compete with one another for binding to LAR-Fc ( Figure 8A ). Dlp-AP SA gave more effective inhibition of binding, with a K i value lower than that of Sdc-AP SA (Figure 8A) . The observed Bmax (maximal amount bound) for SdcAP was similar in the presence or absence of Sdc-AP SA or Dlp-AP SA , indicative of competitive rather than noncompetitive binding inhibition ( Figure 8A and legend). A simple molecular interpretation would be that Sdc and Dlp bind to identical or overlapping binding sites on LAR.
Having shown that Sdc and Dlp compete for LAR binding in vitro and display opposite gain-of-function phenotypes during synapse development in vivo, we then asked if simultaneous elevation of the two genes would reveal which HSPG is dominant in vivo. Thus, we simultaneously elevated both Sdc and Dlp under a single GAL4 driver in a wild-type background and compared the outcome to expression of the single (B) Bouton number was quantified and plotted as percentage change relative to control in larvae overexpressing either Sdc, Dlp, or both under control of 24B-GAL4 to determine which HSPG is dominant in vivo. UAS-Dlp alone was indistinguishable from UASDlp+UAS-Sdc. Light green, blue, and pink horizontal bars represent SEM for UAS-Sdc, 24B-GAL4 control, and UAS-Dlp+UAS-Sdc, respectively. (C) Based on genetic data, LAR functions presynaptically to link bouton growth and active zone formation. Sdc (green) functions with LAR to promote bouton growth (1), a function dependent on LAR catalytic activity. Dlp (red) inhibits LAR activity (2) and is required to regulate active zone formation, presumably by blocking growth signals in favor of other effectors. Biochemical and genetic data suggest that Dlp has a competitive advantage. This leads to a model in which LAR mediates a natural transition between synapse growth and active zone assembly (step 1 to step 2). transgenes under the same driver. We found that coexpression of Sdc and Dlp was indistinguishable from expression of Dlp alone ( Figure 8B ). This demonstrates that Dlp is completely dominant in vivo, consistent with the competitive advantage of Dlp over Sdc for LAR binding in vitro.
Discussion
Converging lines of evidence suggest that membraneassociated HSPGs serve an important purpose in the assembly, function and plasticity of excitatory synapses (reviewed by Van Vactor et al. [2006] and Yamaguchi [2001] ). Here, we demonstrate that the ancient HSPG families of syndecans and glypicans are necessary for Drosophila to regulate distinct aspects of synaptic morphogenesis. Moreover, our genetic and biochemical data indicate that Sdc and Dlp interact with a shared receptor (LAR) to control presynaptic properties. Because LAR-family RPTPs have been shown to control the formation of excitatory synapses in Drosophila, C. elegans, and mammals (Ackley et al., 2005; Dunah et al., 2005; Kaufmann et al., 2002) , our findings may represent a more general mechanism for regulating synaptic morphogenesis and function. Despite the importance of LAR-family RPTPs during cellular morphogenesis inside and outside of the nervous system (reviewed by Johnson and Van Vactor [2003] ), the lack of physiologically relevant extracellular binding partners has made it challenging to study this well-conserved group of receptors.
Syndecan and LAR Promote Synaptic Growth
Our data show that Sdc promotes the formation of presynaptic boutons. This Sdc function appears to be mediated by LAR, as supported by parallel phenotypes, direct binding, in vivo colocalization, and three types of double mutant analysis between Sdc and LAR. Despite the fact that Sdc exhibits gain-of-function activity and endogenous expression on both sides of the synapse, our neuronal and muscle-specific rescue experiments show that Sdc function is mainly presynaptic. Because LAR is required only in neurons to promote synapse growth, our findings support a model in which Sdc acts as a neuronal cell-autonomous agonist of LAR. This is somewhat surprising, given the fact that soluble forms of Sdc bind to LAR and that endogenous Sdc appears to be released from the presynaptic membrane to fill the SSR. One way for Sdc to act presynaptically would be to bind to LAR even before the two proteins are presented on the neuronal surface. Because Dlp has a competitive advantage over Sdc for binding to LAR, a prebound complex of Sdc and LAR would have the ability to stimulate synapse growth before the phosphatase could be inhibited by Dlp. Such a mechanism could provide a time-and/or HSPG concentrationdependent switch from bouton addition to active zone assembly ( Figure 8C ).
Sdc could promote LAR activity in collaboration with an additional cell-type-specific membrane protein.
Data from a parallel study also identified Sdc-LAR interactions during embryonic motor axon guidance (Fox and Zinn, 2005) . However, in contrast to CNS pathfinding (Johnson et al., 2004; Steigemann et al., 2004) , complete loss of Sdc alone has no significant effect on motor pathfinding (Fox and Zinn, 2005 ; this study), suggesting that additional LAR ligands exist in the early embryo. Recent experiments with the vertebrate LAR ortholog PTP-s suggest that non-HSPG ligands may regulate its ability to promote retinal axon outgrowth (Sajnani et al., 2005) . Although it remains a formal possibility, an additional ligand may not be needed to account for the NMJ growth-promoting activity of LAR because the larval synaptic phenotype in Sdc mutants is nearly as strong as the growth defect in LAR mutants (Figure 2 ) (Kaufmann et al., 2002) .
Dallylike and LAR Interact to Control Active Zone Form and Function
Active zone assembly is vital for neurotransmission at the synapse and has been proposed as a means to modulate synaptic function over time (reviewed by Zhai and Bellen [2004] ). Our analysis of Dlp reveals that synaptic glypicans are required to regulate active zone morphology and function. Moreover, we find that Dlp is limiting for active zone morphogenesis, consistent with an instructive role. Because the activities of Dlp appear opposite to those of LAR, we propose that the high affinity binding of Dlp to LAR induces an inhibition of receptor function ( Figure 8C ). This hypothesis is supported by the double RNAi experiments showing that the LAR effect on Ena phosphorylation is epistatic to the effect of Dlp, indicating that Dlp acts upstream of LAR. Because loss of Dlp at the NMJ did not induce a significant change in the number of presynaptic boutons, the results lead to a model in which Dlp is specialized for control of active zone properties. Such a function might provide a means to independently regulate and spatially distinguish LAR inhibition from LAR activation. In any case, the presence of active zone phenotypes in dlp but not in Sdc reveals specialization among synaptic HSPGs.
LAR regulates both NMJ growth and active zone morphogenesis (Kaufmann et al., 2002) . Thus, LAR appears to provide a link between two important synaptic properties that are regulated by different extracellular factors. A mechanism to couple bouton growth and active zone formation would make sense because active zones appear early in the nascent bouton (Zito et al., 1999) . Because LAR catalytic activity is necessary for bouton addition, and yet LAR inhibition by Dlp appears necessary for proper active zone formation, LAR's role at the active zone may be primarily structural. For example, LAR may simply provide an anchorage point for synaptic components like the scaffolding protein Liprin-a that regulates active zone formation (e.g., Kaufmann et al. [2002] ). Alternatively, LAR may exist in distinct yet active signaling states, one of which is dependent on PTP activity (promoting synapse growth), and one of which is dependent on recruitment of signaling molecules (controlling active zone assembly). Because loss of Dlp or LAR has opposite effects on quantal content at the NMJ, it is attractive to speculate that the Dlp-LAR pathway normally provides a means to modulate the strength of neurotransmission, either during NMJ growth or during synaptic plasticity. LAR PTPs are required for normal physiology and plasticity at mammalian hippocampal synapses (Dunah et al., 2005; Uetani et al., 2000) .
HSPG Specificity at the Neuromuscular Junction
Sdc and Dlp are both HSPGs that bind to LAR and thus might be expected to act similarly, but our results show that their functions are different. One way to account for the specificity might be a difference in the effect of soluble versus cell-surface HSPGs on LAR. Some ligand molecules such as Ephrins function when clustered at high density (e.g., on a membrane surface) but fail to activate their receptors when presented in a soluble, monomeric form (reviewed by Flanagan and Vanderhaeghen [1998] ). Another possibility could be that LAR binding or signaling is differentially influenced by direct protein-protein interactions with the Sdc versus Dlp core proteins. The two HSPGs have very different core structures; Sdc is a transmembrane molecule with HS modification sites near the N terminus, whereas Dlp is a GPI-anchored protein with HS sites proximal to the membrane and a large disulphide bonded globular domain located more distally (reviewed by Bernfield et al. [1999] ). It may also be relevant that Dlp consistently bound more effectively to LAR than Sdc, with K D measurements in solution showing an affinity approximately 2-fold higher. These results suggest a competition model in which Dlp displaces Sdc, possibly to favor the stabilization of active zones after new growth at the synapse. In this model, presynaptic growth would be initially promoted by Sdc and would then be limited or halted by Dlp binding after formation of close membrane contact between the nerve and muscle. Such a mechanism could insure a transition from growth to synapse stabilization ( Figure 8C ) and could participate in subsequent maintenance or plasticity of the synapse.
Of course other molecules influence synapse size, and these might include coligands or coreceptors that may bind to Sdc, Dlp, and/or LAR. Potential candidates might include bone morphogenic protein (BMP), the type II BMP receptor Wishful thinking (Wit), or the Wnt ortholog Wingless (Wg), which have all been shown to regulate NMJ morphology in Drosophila (Aberle et al., 2002; Marques et al., 2002; McCabe et al., 2003; Packard et al., 2002) . However, in addition to significant phenotypic differences compared to the HSPGs, overexpression studies indicate that neither BMP nor Wg are limiting for NMJ morphogenesis (Aberle et al., 2002; Packard et al., 2002) . In contrast, Sdc and Dlp are both limiting for different aspects of synapse development, consistent with an instructive role in this context. Consistent with this notion, Syndecan-2 is sufficient to promote dendritic spine maturation during hippocampal synaptogenesis in culture (Ethell and Yamaguchi, 1999) . Although vertebrate Syndecan-2 has yet to be tested at the synapse by loss of function, the colocalization and parallel biology of Synecan-2 and vertebrate LAR-family receptors strongly suggest conservation in the regulation of synaptic LAR (Dunah et al., 2005; Hsueh and Sheng, 1999; Hsueh et al., 1998) .
Conclusions
The genetic and biochemical studies described here identify a partnership between HSPGs and LAR in Drosophila NMJ development that sets precedents for (1) the in vivo requirement for members of the syndecan and glypican families in synapse growth and electrophysiological function, (2) the specificity of HSPG function at the synapse, with distinct actions of Sdc and Dlp, and (3) biochemical identification of Sdc and Dlp as LAR binding partners, plus genetic evidence to place them in a pathway regulating biological function at the synapse.
Experimental Procedures
Genetics Drosophila strains descrbed in Baeg et al. (2001) , Han et al. (2004) , Johnson et al. (2004) , Kaufmann et al. (2002) , Kirkpatrick et al. (2004) , and Luo et al. (1994) were balanced over CyO-[actin-GFP], whereas dlp alleles were balanced over Tm6B- [ubi-GFP] .
Immunohistochemistry of Cells and Tissues
Wandering third instar larvae from sparsely populated bottles were collected and dissected in Ca 2+ -free saline. Several antibodies required a detergent-free protocol to visualize labeling at the NMJ, including anti-Dlar (1:100; gift from H. Saito), anti-Sdc (1:250) (Spring et al., 1994) , and anti-Dlp (1:50) (Lum et al., 2003 (Kaufmann et al., 2002) . Statistical analysis of boutons per NMJ was conducted in Excel by Student's t-test. Confocal microscopy was performed as described (Johnson et al., 2004) .
Fusion Proteins and Binding Assays
AP fusion constructs were generated by inserting ectodomain sequences for Sdc or Dlp in APtag5 (Flanagan et al., 2000) . Fc fusion proteins were in the Ig2eco vector (Cheng and Flanagan, 2001) , and Fc fusion concentration was normalized by Western blot against the human Fc tag (see below). LARDP-FLAG was generated by amplifying the ectodomain and transmembrane domains of LAR with PCR and subcloning into pMTAV5His. The three serine attachment sites were converted to threonine (ST3) to remove the glycosylation sites on Syndecan. Ser109 of APtag-5 was changed to alanine by PCR, generating AP SA to create a catalytically-inactive AP for competition experiments.
Cell-free binding assays were performed with Reacti-Bind Protein A-coated microtitre plates (Pierce). Wells were blocked with HBAH (Hank's Buffered Saline Solution with 0.5 mg/ml BSA and 20 mM Hepes 7.0) for 15 min. DLAR-Fc fusion protein conditioned media (approximately 2 mg/ml) were allowed to bind to protein A for 1.5 hr, room temperature. Wells were then washed four times with HBAH, treated with AP fusion-conditioned medium for 1.5 hr, and then washed and assayed for bound AP activity as described (Flanagan et al., 2000) . For heparitinase treatment, 200 ml of 30 nM AP fusion protein was incubated with 5 mU heparitinase (Seikagaku) or mock treated at 37ºC for 1 hr. The concentration of the ''cold'' HSPG-AP SA fusion proteins used in competition binding experiments was approximately 25 nM as determined by comparison of HSPG-AP SA and HSPG-AP conditioned media by Western blot. Cell surface binding assays were performed as described (Flanagan et al., 2000) by using S2 cells transfected with Fugene (Roche) and grown in suspension or on ConA-treated coverslips.
Protein Sample Preparation, RNA Interference, and Western Blotting Transfected S2 cells were incubated in five volumes of hypotonic lysis buffer (25 mM Tris 7.5, 1 mM DTT, 1 Complete protease inhibitor tablet [Roche]) on ice for 10 min. Lysates were passed through a G27 syringe needle five times, and nuclei were pelleted (5000 RPM, 4ºC, 5 min). The supernatants (membrane fractions) were collected and pelleted (12,000 RPM, 4ºC, 10 min). Pellets were resuspended in 200 ml 13 SDS/PAGE sample buffer.
For Western blot analysis of recombinant protein expression, fusion-protein-conditioned media or S2 cell membrane fractions were subjected to SDS/PAGE on a 9% gel, transferred to Hybond N+ membrane (AP fusion proteins) or PVDF membrane (Fc fusion proteins and S2 cell membrane fractions), and blocked in 4% milk/ TBST for 1 hr. Blots were incubated with primary antibodies overnight at 4ºC, and diluted 1:1000 in 4%milk/TBST: anti-Myc (9E10, Santa Cruz Biotech), anti-human Fc-HRP (Amersham), anti-FLAG (M2 mouse monoclonal, Sigma). Myc/Flag blots were washed five times in TBST and incubated with anti-mouse Fc-HRP (Amersham) 1:1000 in 4%milk/TBST 1 hr. Blots were washed five times in TBST and detected with ECL Plus reagent (Amersham).
Tandem affinity purification (TAP) was modified from Veraksa et al. (2005) (see Supplemental Data). RNA interference was modified from Worby et al. (2001) (see Supplemental Data). On completion of dsRNA treatment, cells were harvested, lysed (lysis buffer same as that used in TAP experiments described above), and an aliquot was used to assess the efficiency of the dsRNA treatment by electrophoresis on a 4%-15% gradient gel and immunoblotting with anti-Dlar (a kind gift of Kai Zinn, 1:100), anti-Dlp (DSHB, 1:1000), or anti-tubulin (Sigma, 1:3000) antibodies. For better resolution of Dlp, the lysate was treated with Heparinase III (Seikagaku) as described in Lum et al., 2003. Ena monoclonal 1G6.C10 antibody was covalently attached to beads with the ProFound Coimmunoprecipitation kit (Pierce), followed by immunoprecipitation from control and dsRNA-treated Kc167 lysates described above by the manufacturer's protocol. After immunoprecipitation, samples were split in half, and electrophoretic separation on two 10% gels performed followed by immunoblotting with either the anti-Ena antibody or a cocktail (1:1 w/w) of rabbit polyclonal anti-phosphotyrosine antibodies (Upstate and Chemicon [AB1599]) used at 2 mg/ml. Densitometric quantification was performed with the ImageJ software. Nitrocellulose membranes (Amersham) were used for all immunoblot experiment except for those involving detection of Dlp in which Hybond N+ membrane (Amersham) was used.
Electrophysiology
Electrophysiology was preformed on late third-instar larvae. Mutant larvae were raised on agar grape plates along with their heterozygous siblings and separated at early third instar. Larvae were dissected in Ca 2+ -free HL-3 saline with the following ionic concentrations (in mM): 70 NaCl, 5 KCl, 20 MgCl 2 , 10 NaHCO3, 5 trehalose, 115 sucrose, and 5 HEPES (pH 7.2) (Stewart et al., 1994) . All recordings were measured in HL-3 saline containing 1 mM Ca 2+ . Sharp microelectrodes (15-30 MOhms) were filled with 3 M KCl and were used to record membrane potentials from muscle six of abdominal segments A3 or A4. Wide bore suction electrodes were used to stimulate the segmental nerve, which was cut free from the ventral nerve cord. Spontaneous events were recorded in the absence of stimuli. Recordings were analyzed only if the resting membrane potential was %256 mV. Muscle input resistance was measured for each genotype and found to be similar to control. Data were collected with a Digidata1322A and Axopatch 2A amplifier (Axon Instruments). Evoked potentials were analyzed with Clampfit8.2 (Axon Instruments), and spontaneous events were analyzed with MiniAnalysis6 software (Synaptosoft, Inc.). The average EJP amplitude was calculated from averages of 20-25 events per each NMJ. 200 events per NMJ were averaged to calculate mini event amplitude while 3 min of recorded minis were used to calculate the mini frequency. Quantal content was corrected for nonlinear summation with the previously published method (McLachlan and Martin, 1981) .
Electron Microscopy
Ultrastructural analysis was performed with modifications from (Kaufmann et al., 2002 ) (see Supplemental Data).
Supplemental Data
The Supplemental Data for this article can be found online at http:// www.neuron.org/cgi/content/full/49/4/517/DC1/.
